Skip to main content
OpenTrials
Completed

NCT Number: NCT00771186

Intraoperative Laryngeal Electromyography (LEMG) in Children With Vocal Fold Immobility: a Longitudinal Study

The goal of this study is to further study the role of LEMG in accurately predicting the recovery of vocal function as well to study the timing of a change of LEMG activity prior to such return of function. We aim to do this by collaborating with several active pediatric otolaryngological practices throughout the country who in turn have agreed to evaluate infants and children with vocal fold immobility who fit a standardized inclusion and exclusion criteria by means of a standardized LEMG protocol over a one year period of time. Our particular goal is to collect and then review information over a one year period of time on all children evaluated for vocal fold immobility by means of LEMG.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, 02114, United States

About this study

Study design:

Primary central hypothesis:

Operative LEMG performed in a serial fashion can predict return of RLN function in children after iatrogenic injury.

Secondary hypothesis:

Operative LEMG performed in a serial fashion will allow some projection as to the timing of RLN recovery

Inclusion criteria

  • Children age 0-18 with vocal fold immobility documented by laryngeal fiberoptic evaluation
  • Children who have had a recent, identifiable cardiac surgical etiology for RLN injury and subsequent VFI
  • Children whose parents sign informed consent and who themselves sign assent if they are old enough to do so.

Exclusion criteria

  • Children whose families do not give informed consent or who themselves do not give informed assent ( if the children are old enough to understand)
  • Children with congenital VFI where the etiology is not clearly identified

Data to be recorded:

  • Age of patient
  • Gender
  • Age of initial fiberoptic evaluation and of initial diagnosis
  • Diagnosis
  • Serial Laryngeal Recordings
  • Fiberoptic Evaluations

LEMG Recording

While in a light plane of anesthesia, the following recordings will be routinely performed:

  • 10 seconds of both right and left vocal fold LEMG simultaneously recorded with a gain of 50 V
  • 10 seconds of both right and left vocal fold LEMG simultaneously recorded with a gain of 200 V
  • 10 seconds of right vocal fold LEMG recorded with a gain of 50 V
  • 10 seconds of right vocal fold LEMG recorded with a gain of 200 V
  • 10 seconds of left vocal fold LEMG recorded with a gain of 50 V
  • 10 seconds of left vocal fold LEMG recorded with a gain of 200 V

Total recording time: 60 seconds

Timing of LEMG and Awake Fiberoptic Laryngoscopy

Following current standard clinical evaluation we are performing at MEEI, we propose to perform awake fiberoptic laryngoscopy and operative LEMG at the following time points: initially (within 3 weeks of injury if possible), at the 3 month post-injury mark, and at the 9- month post injury mark ( 3 recordings in total; we will perform a final fiberoptic laryngoscopy in the office at the one year time interval). The time points were chosen as each recording necessitates an operative procedure with general anesthesia so we wanted to limit the over number of general anesthetics. We recognize that the risk of limiting the number of operative LEMG recordings is that we lose some data-points to chart recovery of RLN function, but we felt that the risks of multiple general anesthetics were sufficient enough to warrant limiting the number of recordings as much as possible.

Data Collection and Database protection

All Data collected will be entered into a password protected database.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children age 0-18 with vocal fold immobility documented by laryngeal fiberoptic evaluation
  • Children who have had a recent, identifiable cardiac surgical etiology for RLN injury and subsequent VFI
  • Children whose parents sign informed consent and who themselves sign assent if they are old enough to do so

Exclusion criteria

  • Children whose families do not give informed consent or who themselves do not give informed assent ( if the children are old enough to understand)
  • Children with congenital VFI where the etiology is not clearly identified

Treatment and study plan

Primary outcomes

  1. return of vocal fold function

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Massachusetts Eye and Ear Infirmary

Other

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Oct 13, 2008
Registry last updated
Jun 22, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.